InsiderTrades

Form 4 for ALT Altimmune, Inc.

Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-11 · accession 0001251779-25-000006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-11-12 2025-11-11 ALT WEAVER GREGORY L CFO F - Tax $4.28 -5,672 23.1K -20% -$24.3K
D 2025-11-12 2025-11-11 ALT WEAVER GREGORY L CFO M - OptEx $0.00 +18.8K 28.8K +188% $0
D 2025-11-12 2025-11-11 ALT WEAVER GREGORY L CFO M - OptEx $0.00 -18.8K 56.2K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.0001 2025-11-11 F D 5,672 $4.28 23,078 D — —
2 Common Common Stock, par value $0.0001 2025-11-11 M A 18,750 $0.00 28,750 D — — (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
3 Derivative Restricted Stock Units 2025-11-11 M D 18,750 $0.00 56,250 D — · — to — 18,750 Common Stock, par value $0.0001 (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F3) The RSUs become vested over four (4) years with 25% of the shares vesting on November 11, 2025, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.